Medicinal Cannabis Matters | Friday roundup 20th December 2024.
Medicinal Cannabis Matters – Our weekly round-up of what has been happening in the world of medicinal cannabis this week. We would also like to wish you a Merry Christmas & a Happy New Year from all the team at Medicann.
This week, we explore groundbreaking research on terpenes and their potential to alleviate post-surgery and fibromyalgia pain. We also delve into the growing trend of athletes incorporating medicinal cannabis into their training and recovery routines. Additionally, we examine how medicinal cannabis treatments may enhance the quality of life for children living with Autism and Epilepsy.
A study shows medicinal cannabis terpenes relieve post-surgery and fibromyalgia pain.
Newly funded research on terpenes from the cannabis plant reveals that certain compounds show potential for alleviating pain associated with fibromyalgia or aiding recovery following surgery.
Medicinal cannabis for athletes for recovery, and performance.
Once thought of as an illegal substance, medicinal cannabis is now being embraced by numerous athletes for training and recovery. Discover how this natural remedy is transforming the world of sports, offering benefits, and hearing firsthand accounts from athletes who have experienced its positive impact.
Medicinal cannabis treatment may significantly improve the quality of life for children with Autism and Epilepsy.
A recent scientific review highlights that cannabis treatments with high CBD and low THC content show significant promise in improving the quality of life for children with Autism and Epilepsy. The findings suggest encouraging results in reducing core symptoms associated with these conditions.
If you’re interested in learning more about medicinal cannabis and how it can help you manage your condition, fill out the simple form linked below. Start your journey today with the only award-winning clinic in Jersey, Guernsey and the Isle of Man. Check your eligibility today.
https://www.medicann.co.uk/book-consultation/eligibility/
Disclaimer:
This blog post and the following featured articles are for information only and any articles on external platforms may be amended at any time. Articles that we refer to in our weekly roundup do not reflect the views of Medicann.
